Confinement Suppresses Mechanical Force‐Mediated Cancer Cell Apoptosis
Source abstract
Abstract
Abstract During the invasion, cancer cells migrate through ‘3D channel‐like tracks’ present in the tissues' interstitial extracellular matrix (ECM). Cancer cell migration through these 3D confined channels leads to confinement‐induced cell deformation. Emerging reports show that cancer cells are susceptible to mechanical stretch/ultrasound (US)‐mediated mechanical forces and undergo calcium‐dependent apoptosis (mechanoptosis) under conditions that promote normal cell growth. Surprisingly, we find that confinement‐induced cell deformation suppresses mechanoptosis. Studies done using microchannel platforms and tumor spheroid models show that a low level of apoptosis is observed in confined cells. Further, apoptosis level is found to increase with a decrease in the degree of confinement. The absence of mature focal adhesions (FAs), low myosin IIA contractility, and diffuse mechanosensitive Piezo1 channels are responsible for a low level of apoptosis in confined cells. Thus, these findings suggest that confined cells, due to the absence of mature FAs, could not sense and transduce the mechanical forces and generate enough myosin IIA contractility required to initiate apoptosis. The combined action of US and activators of myosin contractility can be used to target invading cancer cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cellular Mechanics and Interactions · Erythrocyte Function and Pathophysiology · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering Indian Institute of Science Bangalore 560012 India
Centre for Nanoscience and Engineering Indian Institute of Science Bangalore 560012 India
Mechanobiology Institute National University of Singapore Singapore 117411 Singapore
Plaksha University Mohali 140306 India
Department of Biomedical Engineering National University of Singapore Singapore 117583 Singapore
Funding
Department of Biotechnology, Government of West Bengal · National Research Foundation Singapore
References (57)
Show source-provided references
1. 10.1038/8912610.1038/89126 ↗
2. 10.1242/jcs.05072410.1242/jcs.050724 ↗
3. 10.1007/s00418-008-0529-110.1007/s00418-008-0529-1 ↗
4. 10.4161/intv.2122310.4161/intv.21223 ↗
5. 10.1038/ncb165810.1038/ncb1658 ↗
6. 10.4161/intv.2529410.4161/intv.25294 ↗
7. 10.1016/j.cell.2011.11.01610.1016/j.cell.2011.11.016 ↗
8. 10.1016/j.semcdb.2009.08.00510.1016/j.semcdb.2009.08.005 ↗
9. Kumari A. · ACS Omega · 2023 · 8
10. 10.1096/fj.12-21144110.1096/fj.12-211441 ↗
11. 10.1039/c3ib20196a10.1039/c3ib20196a ↗
12. 10.1073/pnas.111807310910.1073/pnas.1118073109 ↗
13. 10.1152/ajpcell.00225.201410.1152/ajpcell.00225.2014 ↗
14. 10.1038/ncb206210.1038/ncb2062 ↗
15. 10.1021/acs.nanolett.4c0585810.1021/acs.nanolett.4c05858 ↗
16. 10.1002/btm2.1073710.1002/btm2.10737 ↗
17. 10.1038/s41598-018-26198-710.1038/s41598-018-26198-7 ↗
18. 10.1016/j.biomaterials.2021.12086610.1016/j.biomaterials.2021.120866 ↗
19. 10.1038/srep3997510.1038/srep39975 ↗
20. 10.1016/0301-5629(93)90020-O10.1016/0301-5629(93)90020-O ↗
21. 10.1002/btm2.1023310.1002/btm2.10233 ↗
22. 10.1590/s1677-5538.ibju.2018.03.0310.1590/s1677-5538.ibju.2018.03.03 ↗
23. 10.1007/BF0124014610.1007/BF01240146 ↗
24. 10.1530/ERC-17-004510.1530/ERC-17-0045 ↗
25. Lin C. Y. · Int. J. Nanomed. · 2012 · 7 · 1491
26. 10.1083/jcb.20190205710.1083/jcb.201902057 ↗
27. 10.1038/nature0890810.1038/nature08908 ↗
28. 10.1073/pnas.050025410210.1073/pnas.0500254102 ↗
29. 10.1038/nrm390310.1038/nrm3903 ↗
30. Liu Y. J. · Cell · 2015 · 160 · 634
31. 10.1038/s41563-021-01087-z10.1038/s41563-021-01087-z ↗
32. 10.1242/jcs.113.20.367310.1242/jcs.113.20.3673 ↗
33. 10.1038/3504665910.1038/35046659 ↗
34. 10.1088/1367-2630/15/1/01500310.1088/1367-2630/15/1/015003 ↗
35. Pan B. · Oncol. Lett. · 2018 · 15 · 4037
36. 10.1083/jcb.146.6.137510.1083/jcb.146.6.1375 ↗
37. 10.1038/s42003-019-0514-310.1038/s42003-019-0514-3 ↗
38. 10.1126/sciadv.abo146110.1126/sciadv.abo1461 ↗
39. 10.1038/s41556-020-0552-610.1038/s41556-020-0552-6 ↗
40. 10.1186/s12935-021-01898-910.1186/s12935-021-01898-9 ↗
41. 10.26508/lsa.20240260110.26508/lsa.202402601 ↗
42. 10.1038/nature1081210.1038/nature10812 ↗
43. 10.1007/s10120-021-01239-910.1007/s10120-021-01239-9 ↗
44. 10.1038/s41568-018-0038-z10.1038/s41568-018-0038-z ↗
45. 10.3389/fphar.2022.95559510.3389/fphar.2022.955595 ↗
46. 10.1021/nn400202j10.1021/nn400202j ↗
47. 10.1038/s41551-017-0127-410.1038/s41551-017-0127-4 ↗
48. 10.1073/pnas.111988610910.1073/pnas.1119886109 ↗
49. 10.1016/S0092-8674(04)00058-310.1016/S0092-8674(04)00058-3 ↗
50. 10.1016/j.tcb.2006.02.00510.1016/j.tcb.2006.02.005 ↗
51. 10.1038/ncb327710.1038/ncb3277 ↗
52. 10.1021/acsnano.0c0313010.1021/acsnano.0c03130 ↗
53. 10.1021/acsnano.4c0210410.1021/acsnano.4c02104 ↗
54. 10.1002/advs.20230222810.1002/advs.202302228 ↗
55. 10.1126/sciadv.aba650510.1126/sciadv.aba6505 ↗
56. 10.1002/advs.20240161110.1002/advs.202401611 ↗
57. Kingsler L. E. · 2000